You are here

Lyrica

Pfizer's LYRICA Meets Primary Endpoint in Phase III Trial in Pediatric Epilepsy

Pfizer's LYRICA Meets Primary Endpoint in Phase III Trial in Pediatric Epilepsy

CP Wire

pediatric epilepsy

Flag link:

Pfizer's LYRICA Meets Primary Endpoint in Phase III Trial in Pediatric Epilepsy

pediatric epilepsy

Flag link:

Better together? AbbVie’s Humira and Pfizer’s Lyrica again outspend other brands

Better together? AbbVie’s Humira and Pfizer’s Lyrica again outspend other brands

Fierce Pharma

Flag link:

Pfizer's Ibrance hits the TV ad-spending top 10, joining stalwarts Humira and Lyrica

Pfizer's Ibrance hits the TV ad-spending top 10, joining stalwarts Humira and Lyrica

Fierce Pharma

DTC advertising

Flag link:

Neurontin prescriptions surge amid opioid crisis

Neurontin prescriptions surge amid opioid crisis

Reuters

Flag link:

Humira back on top of TV spending list for October, ahead of Lyrica and Victoza

Humira back on top of TV spending list for October, ahead of Lyrica and Victoza

Fierce Pharma

Flag link:

With a year left before generics hit, Pfizer nabs FDA approval for new-and-improved Lyrica

With a year left before generics hit, Pfizer nabs FDA approval for new-and-improved Lyrica

Fierce Pharma

diabetic peripheral neuropathy

Flag link:

Pfizer's Lyrica takes pharma TV spending crown from AbbVie's Humira for September

Pfizer's Lyrica takes pharma TV spending crown from AbbVie's Humira for September

Fierce Pharma

Flag link:

With Viagra and Lyrica fading, analysts downgrade Pfizer due to mounting challenges

With Viagra and Lyrica fading, analysts downgrade Pfizer due to mounting challenges

Fierce Pharma

Flag link:

Viagra, Lyrica among 91 meds to get June price hikes at Pfizer: FT

Viagra, Lyrica among 91 meds to get June price hikes at Pfizer: FT

Fierce Pharma

Flag link:

Pfizer’s Lyrica Ineffective for Sciatica Pain

Pfizer’s Lyrica Ineffective for Sciatica Pain

Investopedia

Flag link:

The 3 Biggest Risks for Pfizer in 2017

The 3 Biggest Risks for Pfizer in 2017

Motley Fool

Flag link:

Pfizer Reports Positive Lyrica Study

Pfizer Reports Positive Lyrica Study

Investopedia

pediatric epilepsy

Flag link:

In October TV pharma ad spending, AbbVie's Humira and Pfizer's Lyrica continue to dominate

In October TV pharma ad spending, AbbVie's Humira and Pfizer's Lyrica continue to dominate

Fierce Pharma

Flag link:

Pfizer Loses U.K. Patent Appeal Over $4.8 Billion Lyrica Drug

Pfizer Loses U.K. Patent Appeal Over $4.8 Billion Lyrica Drug

Bloomberg

Flag link:

AbbVie’s Humira, Pfizer’s Lyrica dominate a year of TV ad spend with almost $500M total

AbbVie’s Humira, Pfizer’s Lyrica dominate a year of TV ad spend with almost $500M total

Fierce Pharma

Flag link:

Drug Commonly Used For Pain And Anxiety May Be Linked To Major Birth Defects

Drug Commonly Used For Pain And Anxiety May Be Linked To Major Birth Defects

Forbes

Flag link:

Pfizer Inc (PFE) Earnings Could Highlight Enbrel and Lyrica Sales Decline

Pfizer Inc (PFE) Earnings Could Highlight Enbrel and Lyrica Sales Decline

Bidness, ETC

Flag link:

AbbVie's Humira, Pfizer's Lyrica kick off 2016 with hefty TV ad spend

AbbVie's Humira, Pfizer's Lyrica kick off 2016 with hefty TV ad spend

Fierce Pharma Marketing

Flag link:

Pfizer recalls 3 lots of Lyrica after heat damage

Pfizer recalls 3 lots of Lyrica after heat damage

BioPharma Dive

Flag link:

Pages